Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Asset Writedowns and Impairment (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Asset Writedowns and Impairment for 13 consecutive years, with $129000.0 as the latest value for Q4 2025.

  • Quarterly Asset Writedowns and Impairment rose 29.0% to $129000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $129000.0 through Dec 2025, down 35.5% year-over-year, with the annual reading at $129000.0 for FY2025, 35.5% down from the prior year.
  • Asset Writedowns and Impairment hit $129000.0 in Q4 2025 for STRATA Skin Sciences, up from -$166000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $138000.0 in Q3 2023 to a low of -$166000.0 in Q3 2025.
  • Historically, Asset Writedowns and Impairment has averaged $23000.0 across 5 years, with a median of $42000.0 in 2021.
  • Biggest YoY gain for Asset Writedowns and Impairment was 700.0% in 2021; the steepest drop was 2800.0% in 2021.
  • Year by year, Asset Writedowns and Impairment stood at $27000.0 in 2021, then soared by 207.41% to $83000.0 in 2022, then skyrocketed by 66.27% to $138000.0 in 2023, then decreased by 27.54% to $100000.0 in 2024, then grew by 29.0% to $129000.0 in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for SSKN at $129000.0 in Q4 2025, -$166000.0 in Q3 2025, and $56000.0 in Q2 2025.